150 related articles for article (PubMed ID: 28971394)
1. Chronic Lymphocytic Leukemia Patient Clustering Based on Somatic Hypermutation (SHM) Analysis.
Polychronidou E; Xochelli A; Moschonas P; Papadopoulos S; Hatzidimitriou A; Vlamos P; Stamatopoulos K; Tzovaras D
Adv Exp Med Biol; 2017; 988():127-138. PubMed ID: 28971394
[TBL] [Abstract][Full Text] [Related]
2. Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity.
Sofou E; Zaragoza-Infante L; Pechlivanis N; Karakatsoulis G; Notopoulou S; Stavroyianni N; Psomopoulos F; Georgiou E; de Septenville AL; Davi F; Agathangelidis A; Chatzidimitriou A; Stamatopoulos K
Front Oncol; 2022; 12():1079772. PubMed ID: 36591518
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia.
Agathangelidis A; Rosenquist R; Davi F; Ghia P; Belessi C; Hadzidimitriou A; Stamatopoulos K
Methods Mol Biol; 2019; 1881():51-62. PubMed ID: 30350197
[TBL] [Abstract][Full Text] [Related]
4. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.
Hervé M; Xu K; Ng YS; Wardemann H; Albesiano E; Messmer BT; Chiorazzi N; Meffre E
J Clin Invest; 2005 Jun; 115(6):1636-43. PubMed ID: 15902303
[TBL] [Abstract][Full Text] [Related]
5. Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
Xochelli A; Baliakas P; Kavakiotis I; Agathangelidis A; Sutton LA; Minga E; Ntoufa S; Tausch E; Yan XJ; Shanafelt T; Plevova K; Boudjogra M; Rossi D; Davis Z; Navarro A; Sandberg Y; Vojdeman FJ; Scarfo L; Stavroyianni N; Sudarikov A; Veronese S; Tzenou T; Karan-Djurasevic T; Catherwood M; Kienle D; Chatzouli M; Facco M; Bahlo J; Pott C; Pedersen LB; Mansouri L; Smedby KE; Chu CC; Giudicelli V; Lefranc MP; Panagiotidis P; Juliusson G; Anagnostopoulos A; Vlahavas I; Antic D; Trentin L; Montillo M; Niemann C; Döhner H; Langerak AW; Pospisilova S; Hallek M; Campo E; Chiorazzi N; Maglaveras N; Oscier D; Gaidano G; Jelinek DF; Stilgenbauer S; Chouvarda I; Darzentas N; Belessi C; Davi F; Hadzidimitriou A; Rosenquist R; Ghia P; Stamatopoulos K
Clin Cancer Res; 2017 Sep; 23(17):5292-5301. PubMed ID: 28536306
[No Abstract] [Full Text] [Related]
6. Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy.
Tsakou E; Agathangelidis A; Agathagelidis A; Boudjoghra M; Raff T; Dagklis A; Chatzouli M; Smilevska T; Bourikas G; Merle-Beral H; Manioudaki-Kavallieratou E; Anagnostopoulos A; Brüggemann M; Davi F; Stamatopoulos K; Belessi C
Mol Med; 2012 Feb; 18(1):138-45. PubMed ID: 21968789
[TBL] [Abstract][Full Text] [Related]
7. Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic Leukemia.
Rovida A; Maccalli C; Scarfò L; Dellabona P; Stamatopoulos K; Ghia P
Clin Cancer Res; 2021 Feb; 27(3):729-739. PubMed ID: 33051305
[TBL] [Abstract][Full Text] [Related]
8. The
Perez-Chacon G; Zapata JM
Front Immunol; 2021; 12():627602. PubMed ID: 33912159
[TBL] [Abstract][Full Text] [Related]
9. Antigen receptor stereotypy in chronic lymphocytic leukemia.
Stamatopoulos K; Agathangelidis A; Rosenquist R; Ghia P
Leukemia; 2017 Feb; 31(2):282-291. PubMed ID: 27811850
[TBL] [Abstract][Full Text] [Related]
10. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
[TBL] [Abstract][Full Text] [Related]
11. IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.
Belessi CJ; Davi FB; Stamatopoulos KE; Degano M; Andreou TM; Moreno C; Merle-Béral H; Crespo M; Laoutaris NP; Montserrat E; Caligaris-Cappio F; Anagnostopoulos AZ; Ghia P
Eur J Immunol; 2006 Jul; 36(7):1963-74. PubMed ID: 16783849
[TBL] [Abstract][Full Text] [Related]
12. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.
Murray F; Darzentas N; Hadzidimitriou A; Tobin G; Boudjogra M; Scielzo C; Laoutaris N; Karlsson K; Baran-Marzsak F; Tsaftaris A; Moreno C; Anagnostopoulos A; Caligaris-Cappio F; Vaur D; Ouzounis C; Belessi C; Ghia P; Davi F; Rosenquist R; Stamatopoulos K
Blood; 2008 Feb; 111(3):1524-33. PubMed ID: 17959859
[TBL] [Abstract][Full Text] [Related]
13. B cell receptor and antigens in CLL.
Agathangelidis A; Ntoufa S; Stamatopoulos K
Adv Exp Med Biol; 2013; 792():1-24. PubMed ID: 24014290
[TBL] [Abstract][Full Text] [Related]
14. Stereotyped B Cell Receptor Immunoglobulins in B Cell Lymphomas.
Agathangelidis A; Psomopoulos F; Stamatopoulos K
Methods Mol Biol; 2019; 1956():139-155. PubMed ID: 30779034
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia.
Rani L; Mathur N; Gogia A; Vishnubhatla S; Kumar L; Sharma A; Dube D; Kaur P; Gupta R
Leuk Lymphoma; 2016 Oct; 57(10):2389-400. PubMed ID: 26942309
[TBL] [Abstract][Full Text] [Related]
16. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process.
Messmer BT; Albesiano E; Messmer D; Chiorazzi N
Blood; 2004 May; 103(9):3490-5. PubMed ID: 14695232
[TBL] [Abstract][Full Text] [Related]
17. Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach.
Colombo M; Bagnara D; Reverberi D; Matis S; Cardillo M; Massara R; Mastracci L; Ravetti JL; Agnelli L; Neri A; Mazzocco M; Squillario M; Mazzarello AN; Cutrona G; Agathangelidis A; Stamatopoulos K; Ferrarini M; Fais F
Mol Med; 2020 Mar; 26(1):25. PubMed ID: 32156260
[TBL] [Abstract][Full Text] [Related]
18. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.
Agathangelidis A; Darzentas N; Hadzidimitriou A; Brochet X; Murray F; Yan XJ; Davis Z; van Gastel-Mol EJ; Tresoldi C; Chu CC; Cahill N; Giudicelli V; Tichy B; Pedersen LB; Foroni L; Bonello L; Janus A; Smedby K; Anagnostopoulos A; Merle-Beral H; Laoutaris N; Juliusson G; di Celle PF; Pospisilova S; Jurlander J; Geisler C; Tsaftaris A; Lefranc MP; Langerak AW; Oscier DG; Chiorazzi N; Belessi C; Davi F; Rosenquist R; Ghia P; Stamatopoulos K
Blood; 2012 May; 119(19):4467-75. PubMed ID: 22415752
[TBL] [Abstract][Full Text] [Related]
19. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia.
Capello D; Guarini A; Berra E; Mauro FR; Rossi D; Ghia E; Cerri M; Logan J; Foà R; Gaidano G
Leukemia; 2004 Dec; 18(12):1941-7. PubMed ID: 15483675
[TBL] [Abstract][Full Text] [Related]
20. IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications.
Vardi A; Agathangelidis A; Sutton LA; Chatzouli M; Scarfò L; Mansouri L; Douka V; Anagnostopoulos A; Darzentas N; Rosenquist R; Ghia P; Belessi C; Stamatopoulos K
Clin Cancer Res; 2014 Jan; 20(2):323-30. PubMed ID: 24240110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
